← Leaderboards
Albert Niden
University Of Southern California
$349,725
Attributed
$349,725
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $128.1K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$349,725 · 4
By mechanism
M01$349,725 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Zea Borok$23,656,539
- Nunzio Bottini$23,475,201
- Derick S Han$2,328,315
- David Gelmont$191,317
- Beiyun Zhou$3,135,176
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchBinding (Molecular Function)United States National Institutes Of HealthIdiopathic Pulmonary FibrosisImmunoglobulin GInstitutionRecombinant ProteinsRecombinantsResearch PersonnelResourcesRespiratory Disorder ChemotherapySourceTnf GeneTumor Necrosis Factor AlphaTumor Necrosis Factor ReceptorComputer Retrieval Of Information On Scientific Projects DatabaseCytokine ReceptorsEtanerceptFundingGrantHamman-Rich SyndromeMediator Of Activation ProteinClinical Trial Phase IInflammatory
Grant awards (8)
CLINICAL TRIAL: ENBREL (TNFR:FC) IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROS$2,320
M01 · FY2009 · RR · contact PI
ENBREL (TNFR:FC) IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS$15,621
M01 · FY2008 · RR · contact PI
ENBREL (TNFR:FC) IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS$12,598
M01 · FY2007 · RR · contact PI
ENBREL (TNFR:FC) IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS$39,193
M01 · FY2006 · RR · contact PI
ENBREL (TNFR:FC) IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS$128,086
M01 · FY2005 · RR
Enbrel (TNFR:FC) in the Treatment of IPF$151,907
M01 · FY2004 · RR
ENBREL (TNFR:FC) TO TREAT OF IDIOPATHIC PULMONARY FIBROS$0
M01 · FY2000 · RR
ENBREL (TNFR:FC) TO TREAT OF IDIOPATHIC PULMONARY FIBROS$0
M01 · FY2000 · RR